Clinical trials for Mumps

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Mumps. For all clinical trials, go to clinical trials search

This list shows clinical trials for Mumps

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Mumps
Title Recruitment status Location
Baby Vaccine Study (Sched3) Not recruiting United Kingdom
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants Not recruiting United Kingdom
The DECIDA study: Detailed Evaluation of a Childhood Immunisation Decision Aid Not Recruiting United Kingdom
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi Pasteur MSD’s dTpa-IPV vaccine (Repevax), when co-administered with GSK Biologicals’ MMR vaccine (Priorix) in 3 and 4-year-old healthy children. - DTPA-IPV (BOOSTRIX-IPV)-009 Authorised United Kingdom
A Study of the Interaction between BCG And Meningitis C immunisation: BAM Authorised United Kingdom
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant Recruiting United States
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants Recruiting Israel
Safety and efficacy of live attenuated vaccine in patients received hematopoietic stem cell transplantation Recruiting Japan
A Randomized, double-blind, positive vaccine-controlled phase II clinical trial of mumps attenuated live vaccine (human diploid cells) in Healthy infants and young children aged 8 months to 24 months Recruiting China
Immunogenicity and safety assessments of MMR vaccine with new mumpes component (RS12) Recruiting Iran, Islamic Republic Of

Page last reviewed: 07/08/2015

Next review due: 01/08/2018